Author

Iván López-Méndez

Observed names: I López-Mendéz, I López-Méndez, I. Lopez-Mendez, I. López-Méndez, Ivan Lopez-Mendez, Ivan López-Mendez, Iván Lopez-Méndez, Iván López-Mendez

Institutions: Hospital Médica Sur, Hospital Central Militar

Observed institutions: Hospital Médica Sur, Hospital Central Militar

ORCID: 0000-0002-1614-1022

Observed ORCID: 0000-0002-1614-1022

OpenAlex ID: A5089209036

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

2020 · Ivan Lopez-Mendez, Jorge Aquino-Matus, et al. · Annals of Hepatology · 66

Diagnostic Accuracy of the Triglyceride–Glucose Index (TyG), TyG Body Mass Index, and TyG Waist Circumference Index for Liver Steatosis Detection

2024 · Alejandra Mijangos-Trejo, Raúl Gómez-Mendoza, et al. · Diagnostics · 18

PDF

Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients

2022 · Ana Luisa Ordoñez-Vázquez, Eva Juárez-Hernández, et al. · International Journal of Environmental Research and Public Health · 15

PDF

Sarcopenia in chronic liver diseases: a translational overview

2020 · Varenka J. Barbero-Becerra, Iván López-Méndez, et al. · Expert Review of Gastroenterology & Hepatology · 11

Hunger & satiety signals: another key mechanism involved in the NAFLD pathway

2023 · Iván López-Méndez, Andrea Del Carmen Maldonado-Rojas, et al. · Frontiers in Endocrinology · 9

PDF

Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments?

2022 · Eva Juárez-Hernández, Alain P. Velázquez-Alemán, et al. · Frontiers in Endocrinology · 9

PDF

Analysis of circulating blood and tissue biopsy PDX1 and MSX2 gene expression in patients with pancreatic cancer: A case–control experimental study

2019 · Gilberto Duarte-Medrano, Iván Lopez-Méndez, et al. · Medicine · 8

Body composition differences in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

2024 · Karen D. Bernal-Contreras, Montserrat Berrospe-Alfaro, et al. · Frontiers in Nutrition · 7

PDF

G protein-coupled receptors: Key molecules in metabolic associated fatty liver disease development

2020 · Iván López-Méndez, Karla Méndez-Maldonado, et al. · Nutrition Research · 7

Immunonutrition: Another Player on the MASLD Field

2025 · Iván López-Méndez, Misael Uribe, et al. · International Journal of Molecular Sciences · 4

PDF

Metabolic Impact of Alcohol Consumption in MASLD: Understanding MetALD and Beyond

2025 · Eva Juárez-Hernández, Montserrat Berrospe-Alfaro, et al. · Journal of Clinical and Experimental Hepatology · 4

PDF

Early portal hypertension in metabolic dysfunction-associated steatotic liver disease: a concise review

2025 · Iván López-Méndez, Eva Juárez-Hernández, et al. · Expert Review of Gastroenterology & Hepatology · 4

Ampullary neuroendocrine tumor: endoscopic papillectomy, an effective and safe treatment

2024 · Ana Luisa Ordóñez-Vázquez, Javier Lizardi-Cervera, et al. · Gastrointestinal Endoscopy · 4

Low–Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease

2023 · Julia Zuarth-Vázquez, Lidia Moreno-Castañeda, et al. · Life · 4

PDF

A 57 year old man with chronic renal failure and cardiac tamponade who developed ischemic hepatitis

2006 · Eric López-Méndez, Eduardo López-Méndez, et al. · Annals of Hepatology · 4

PDF

Factors associated with obtaining lower IQR-CAP values in the detection of hepatic steatosis by transient elastography

2024 · Iván López-Mendez, Juan Luis Romero-Flores, et al. · Annals of Hepatology · 2

Accuracy of Narrow-Band Imaging International Colorectal Endoscopic Classification for Predicting the Histology of Colon Polyps by Experienced Endoscopists and Trainees

2023 · Ramón Mena-Ramírez, Andres Macari-Jorge, et al. · The Turkish Journal of Gastroenterology · 2

PDF

Zinc supplementation in patients with cirrhosis and dysgeusia: Randomized Clinical Trial

2024 · Eva Juárez-Hernández, Iván López-Méndez, et al. · Proceedings of Scientific Research Universidad Anáhuac Multidisciplinary Journal of Healthcare · 1

Effect of zinc supplementation in patients with cirrhosis and dysgeusia

2022 · E. Juárez-Hernández, I. López-Méndez, et al. · Annals of Hepatology · 1

PDF

Association between hypothyroidism and non-alcoholic fatty liver disease

2022 · J Zuarth-Vázquez, JP Soriano-Márquez, et al. · Annals of Hepatology · 1

Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

2021 · Ivan López-Mendez, Graciela Castro-Narro · Annals of Hepatology · 1

Hepatic and gastrointestinal manifestations of SARS-COV-2 infection (COVID-19)

2020 · J. Aquino-Matus, I. Lopez-Mendez, et al. · Annals of Hepatology · 1

Prospective comparative assessment of liver stiffness and steatosis between iLivTouch and FibroScan

2026 · Frida Nuñez-Mercado, Eva Juárez-Hernández, et al. · Hepatology Communications

Endoscopic bariatric and metabolic therapies for metabolic dysfunction-associated steatohepatitis: From weight loss to liver direct outcomes. Is it possible to include them as a therapeutic option?